MacuLogix raises USD3.6m in series A round
MacuLogix, a specialist in the early detection and tracking of age-related macular degeneration (AMD), has raised USD3.6m in series A funding. Investors include Berwind Private Equity, Roche Venture Fund, Life Sciences Greenhouse of Central Pennsylvania, and Ben Franklin Technology Partners of Central and Northern Pennsylvania. The funds will be used

